-
Company Bundle
![]()
Bundle: Artificial Intelligence – Pioneers in Pharma
Gain a 360-degree view of the Artificial Intelligence theme and make more informed decisions for your business. Bundle: Artificial Intelligence – Pioneers in Pharma bundle is a cost-effective solution as it provides access to multiple Company Profiles at a discounted price. Access exclusive data from a trusted intelligence provider with decades of experience serving the most successful companies in the world.
Add to Basket -
Company Bundle
![]()
Bundle: Digital Therapeutics – Pioneers in Pharma
Gain a 360-degree view of the Digital Therapeutics theme and make more informed decisions for your business. Bundle: Digital Therapeutics – Pioneers in Pharma bundle is a cost-effective solution as it provides access to multiple Company Profiles at a discounted price. Access exclusive data from a trusted intelligence provider with decades of experience serving the most successful companies in the world.
Add to Basket -
Company Bundle
![]()
Bundle: Wearable Tech – Pioneers in Pharma
Gain a 360-degree view of the Wearable Tech theme and make more informed decisions for your business. Bundle: Wearable Tech – Pioneers in Pharma bundle is a cost-effective solution as it provides access to multiple Company Profiles at a discounted price. Access exclusive data from a trusted intelligence provider with decades of experience serving the most successful companies in the world.
Add to Basket -
Company Profile
![]()
UroGen Pharma Ltd – Company Profile
UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd, is a biopharmaceutical company that develops novel medicines to treat cancer indications and urologic diseases. The company products include Jelmyto is a drug formulation of mitomycin used to treat low-grade upper tract urothelial cancer. Its pipeline products include UGN-102 is a mitomycin gel is used to treat low-grade intermediate risk non-muscle invasive bladder cancer, UGN-201 and UGN-302 targets high-grade non-muscle invasive bladder cancer and Botox or RTgel for the treatment of overactive...
Add to Basket -
Company Profile
![]()
Xeris Biopharma Holdings Inc – Company Profile
Xeris Biopharma Holdings Inc (XERIS) is the specialty pharmaceutical company that develops novel technology platforms to develop and commercialize stable injectable and infusible drug formulations. The company’s XeriSol formulation technology enables the subcutaneous and intramuscular delivery of concentrated formulations of proteins, peptides, antibodies and small molecules using syringes, multi-dose pens, auto-injectors and pumps. XERIS’s products are used in therapeutic areas such as severe hypoglycemia, post-bariatric hypoglycemia, congenital hyperinsulinism, hypoglycemia-associated autonomic failure, exercise-induced hypoglycemia, acute repetitive seizures and type 1/type 2...
Add to Basket -
Company Profile
![]()
Curevac NV – Company Profile
Curevac NV (Curevac) is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger rna molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its product pipeline includes Cv0501, Cv2cov, Flu Sv Mrna and Cvsqiv. Curevac mrna-based prophylactic vaccines candidates comprise cv7202 and cv8102. it also carries out the research and development. The company Cv8102, a lead oncology candidate is designed to modulate the tumor microenvironment. Its products are used...
Add to Basket -
Company Profile
![]()
Precigen Inc – Company Profile
Precigen Inc (Precigen), formerly Intrexon Corp, is a clinical stage biotechnology company that develops synthetic biology solutions. It offers clinical and pre clinical products. The company clinical products include PRGN-3006, PRGN-3005, AG019, PRGN-2009, PRGN-2012 and PRGN-3007. The company's pre clinical product portfolio comprises of PRGN-3008, PRGN-5001,PRGN-2010, PRGN-2011, PRGN-5002, PRGN-2013, AG017, PRGN-3009 and PRGN-3010. Precigen provides treatment in areas of immuno-oncology, autoimmune disorders, infectious diseases, solid tumors, celiac disease, heart failure, ovarian cancer and type 1 diabetes. It therapeutics platforms include...
Add to Basket -
Company Profile
![]()
Jounce Therapeutics Inc – Company Profile
Jounce Therapeutics Inc (Jounce Therapeutics) is a clinical stage immunotherapy company. It develops therapies that enable the immune system to attack tumors. The company’s major pipeline products include Vopratelimab, an IgG1 monoclonal antibody that activates T cells through ICOS, JTX-8064, an LILRB2 inhibitor novel antibody, JTX-1484, target is LILRB4, pimivalimab target receptor is PD-1, GS-1811, target receptor is CCR8. Its discovery programs include LILRB1, treatment of myeloid and lymphoid cancers. Jounce offers services in the areas of tumor immunology, antibody...
Add to Basket -
Company Profile
![]()
Forma Therapeutics Inc – Company Profile
Forma Therapeutics Inc (Forma) a subsidiary of Novo Nordisk AS, is a biotech company. It develops technologies to identify the initial molecules that provide drug discovery program. It offers research in the areas of tumor metabolism, protein homeostasis, epigenetics, and protein-protein interactions. FORMA’s drug development process includes computational and medicinal chemistry, parallel synthesis, X-ray crystallography, and relevant biology studies. The company collaborates with biotechnology companies, pharmaceuticals and biomedicine companies and research institutes for its research and development activities. It operates...
Add to Basket -
Company Profile
![]()
IVERIC bio Inc – Company Profile
IVERIC bio Inc (IVERIC bio), formerly known as Ophthotech Corp, is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt disease. It provides Fovista, an anti-platelet-derived growth factor (PDGF). IVERIC bio offers gene therapy research programs, dry age-related macular degeneration and ophthalmic orphan programs. The company seeks to collaborate with companies and academic institutions to develop gene therapy product...
Add to Basket
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.